TITLE

The Other Diabetes

AUTHOR(S)
WALDEN, TIFFANY
PUB. DATE
November 2015
SOURCE
Ebony;Nov2015, Vol. 71 Issue 1, p76
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses Type 1 diabetes, also known as juvenile diabetes. Topics discussed include the American Diabetes Association (ADA) estimating 29 million U.S. residents living with some form of diabetes and a projection from the U.S. Census Bureau that minorities from lower-income families making up half of all type 1 cases by 2050. Also mentioned are descriptions of three main types of diabetes as well as the availability of a basal-bolus insulin injection regimen for diabetics.
ACCESSION #
110330962

 

Related Articles

  • Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes. Jornayvaz, François // JGIM: Journal of General Internal Medicine;Feb2014, Vol. 29 Issue 2, p356 

    The author comments on the study conducted by A. R. Patrick and his team which compared the treatment intensification and insulin initiation pattern among type 2 diabetes patients with European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA) guidelines. He...

  • 7. Approaches to Glycemic Treatment.  // Diabetes Care;2015 Supplement, Vol. 38, pS41 

    The article focuses on glycemic treatment approaches for type 1 diabetes patients according to the American Diabetes Association's Standards of Medical Care in Diabetes. Topics discussed include treatment with multiple-dose insulin (MDI) injections or continuous subcutaneous insulin infusion...

  • What the primary healthcare worker needs to know about the management of type 2 diabetes. Mollentze, W. F. // South African Family Practice;Apr/May2012, Vol. 54 Issue 2, pS20 

    The article discusses the clinical management of type 2 diabetes. All type 2 diabetic patients are advised to exercise regularly if there are no associated contraindications. The American Diabetes Association's (ADA) recommended approach to diabetes are metformin, lifestyle interventions and...

  • Cost-Effectiveness of Sulfonylureas versus Metformin as First-Line Therapy in Newly Diagnosed Type 2 Diabetes. Willis, Michael; Borg, Sixten; Persson, Ulf; Neslusan, Cheryl // Diabetes;Jun2007 Supplement 1, Vol. 56, pA318 

    Although long-term outcomes trials have demonstrated that intensive drug therapy improves Type 2 Diabetes outcomes by delaying complications, uncertainty remains regarding which therapies should be used and when. Recently the ADA and EASD issued a consensus statement recommending the use of...

  • American Diabetes Association Annual Meeting, 1999. Bloomgarden, Zachary T. // Diabetes Care;Mar2000, Vol. 23 Issue 3, p405 

    Part V. Focuses on the topics discussed during the American Diabetes Association Annual Meeting and Scientific Sessions held in San Diego, California in June 1999 about the treatment of type 2 diabetes. Algorithmic approaches to combination treatment of type 2 diabetes; Use of meglitinides and...

  • Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries. Lakkis, Najla A; Maalouf, Grace J; Mahmassani, Dina M; Hamadeh, Ghassan N // Family Practice;Oct2013, Vol. 30 Issue 5, p560 

    Background. Studies assessing attitudes and beliefs of physicians regarding insulin therapy in Arab countries are scant despite the high prevalence of type 2 diabetes mellitus (T2DM). Objective. This study examines family physicians’ attitudes and beliefs towards insulin therapy in T2DM...

  • Treatment guidelines reflect new diabetes drugs. Rodgers, Katie // Drug Topics;11/20/95, Vol. 139 Issue 22, p48 

    Reports on a consensus statement developed by the American Diabetes Association that reflects the availability of new classes of drugs to treat noninsulin-dependent diabetes mellitus (NIDDM).

  • Data growing on diabetes prevention, insulin resistance. Henahan, Sean // Drug Topics;Aug96, Vol. 140 Issue 15, p66 

    Reports that clinical studies suggest that it may be possible to prevent or cure Type II, or noninsulin-dependent diabetes (NIDDM) according to researchers at the 1996 meeting of the American Diabetes Association. Results of clinical trial conducted in China; Effect of chromium; Launching of...

  • Generics Help Keep Cost of Treating Diabetes Down.  // Chain Drug Review;9/30/2013, Vol. 35 Issue 15, p88 

    Several studies on cost associated with type 2 diabetes in the U.S. revealing 245 billion dollars reported in 2012 by American Diabetes Association (ADA), 85,000 dollars by a study published in American Journal of Preventive Medicine, and oral treatment reported by Consumer Reports magazine.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics